Medifast (FRA:MDF) Tariff Resilience Score: 7/10 (As of Jun. 29, 2026)


FRA:MDF Medifast Inc FRA:MDF
70 GF Score
Price €8.44
GF Value €7.03
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast Tariff Resilience Score?

Medifast FRA:MDF -7.25% 70 Tariff Resilience Score is 7 as of Jun. 29, 2026. GuruFocus rates FRA:MDF with a GF Score™ of 70/100 and a GF Value™ of €7.03 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 96 Personal Services companies, Medifast ranks better than 92.71% on this metric.

Medifast has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Medifast has Medifast has a relatively resilient position due to its domestic manufacturing and primary sales in the US. It has limited exposure to international tariffs and can adjust pricing if necessary. Historical impacts have been minimal, and it has strong supplier relationships.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Medifast might have Highly Resilient.

Medifast  (FRA:MDF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Medifast Tariff Resilience Score Related Terms

FRA:MDF vs RGS, EVTK, DROR: Tariff Resilience Score Comparison

For the Personal Services subindustry, Medifast's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medifast Tariff Resilience Score vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Medifast's Tariff Resilience Score falls into.


FRA:MDF
70GF Score
Medifast Inc FRA:MDF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Medifast (FRA:MDF) has a Tariff Resilience Score of 7 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Medifast ranks #7 out of 96 companies in the Personal Services industry, placing it in the top 7.3%.
Is Medifast's Tariff Resilience Score too high?
Medifast's current Tariff Resilience Score is 7. Based on the distribution chart, Medifast ranks #7 out of 96 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Tariff Resilience Score compare to RGS and EVTK?
According to the Personal Services industry distribution chart, Medifast ranks #7 out of 96 companies for Tariff Resilience Score. This places Medifast in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Personal Services company?
A good Tariff Resilience Score depends on the Personal Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Medifast's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Modestly Overvalued. The stock's GF Value™ is €7.03, compared to a current price of €8.44 — trading 20.1% above its estimated fair value. The current Tariff Resilience Score is 7. Medifast's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Medifast (FRA:MDF), the current Tariff Resilience Score is 7 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (FRA:MDF) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of €8.44 is trading 20.1% above its estimated GF Value™ of €7.03. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for FRA:MDF:

  • Tariff Resilience Score: 7
  • GF Value™: €7.03 vs. price of €8.44 (20.1% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
70GF Score

Get the complete analysis for FRA:MDF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.44
Price
€7.03
GF Value